Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study

INTRODUCTION: Patients with distributive shock who require high dose vasopressors have a high mortality. Angiotensin II (ATII) may prove useful in patients who remain hypotensive despite catecholamine and vasopressin therapy. The appropriate dose of parenteral angiotensin II for shock is unknown. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Chawla, Lakhmir S, Busse, Laurence, Brasha-Mitchell, Ermira, Davison, Danielle, Honiq, Jacqueline, Alotaibi, Ziyad, Seneff, Michael G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212099/
https://www.ncbi.nlm.nih.gov/pubmed/25286986
http://dx.doi.org/10.1186/s13054-014-0534-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212099/
https://www.ncbi.nlm.nih.gov/pubmed/25286986
http://dx.doi.org/10.1186/s13054-014-0534-9

Ejemplares similares